1. Home
  2. IQV

IQV

IQVIA Holdings Inc.

Logo IQVIA Holdings Inc.

Health Care

Biotechnology: Commercial Physical & Biological Resarch

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Founded: 1982 Country:
United States
United States
Employees: N/A City: DURHAM
Market Cap: 44.7B IPO Year: 2013
Target Price: $256.80 AVG Volume (30 days): 976.1K
Analyst Decision: Buy Number of Analysts: 16
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 7.29 EPS Growth: 27.45
52 Week Low/High: $167.42 - $261.73 Next Earning Date: 04-25-2024
Revenue: $14,984,000,000 Revenue Growth: 3.98%
Revenue Growth (this year): 4.71% Revenue Growth (next year): 7.27%

Share on Social Networks: